Gufic Biosciences (BOM:509079) Loans Receivable: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:509079 Gufic Biosciences Ltd BOM:509079
73 GF Score
Price ₹409.05
GF Value ₹426.01
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Gufic Biosciences Loans Receivable?

Gufic Biosciences BOM:509079 -0.47% 73 Loans Receivable is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:509079 with a GF Score™ of 73/100 and a GF Value™ of ₹426.01 (Fairly Valued). The stock has 5 warning signs investors should review.

Gufic Biosciences's Loans Receivable for the quarter that ended in Jun. 2026 was ₹0 Mil.

Gufic Biosciences Loans Receivable Related Terms

Gufic Biosciences Loans Receivable Historical Data

* Premium members only.

The historical data trend for Gufic Biosciences's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gufic Biosciences Loans Receivable Chart

Gufic Biosciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Gufic Biosciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:509079
73GF Score
Gufic Biosciences Ltd BOM:509079
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gufic Biosciences Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of ₹0 Mil mean?
Gufic Biosciences (BOM:509079) has a Loans Receivable of ₹0 Mil as of Jun. 2026. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Gufic Biosciences and its competitors.
Is Gufic Biosciences' Loans Receivable too high?
Gufic Biosciences' current Loans Receivable is ₹0 Mil. Overall, Gufic Biosciences has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Gufic Biosciences' Loans Receivable compare to ZTS?
Gufic Biosciences' Loans Receivable of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Drug Manufacturers company?
A good Loans Receivable depends on the Drug Manufacturers industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Gufic Biosciences and its competitors. Gufic Biosciences's current Loans Receivable is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gufic Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Gufic Biosciences (BOM:509079) is currently considered Fairly Valued. The stock's GF Value™ is ₹426.01, compared to a current price of ₹409.05 — trading 4% below its estimated fair value. The current Loans Receivable is ₹0 Mil. Gufic Biosciences' overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For Gufic Biosciences (BOM:509079), the current Loans Receivable is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gufic Biosciences (BOM:509079) Overvalued in 2026?

Based on GuruFocus' analysis, Gufic Biosciences stock appears to be undervalued. The current stock price of ₹409.05 is trading 4% below its estimated GF Value™ of ₹426.01. GuruFocus considers Gufic Biosciences to be Fairly Valued.

Key valuation signals for BOM:509079:

  • Loans Receivable: ₹0 Mil
  • GF Value™: ₹426.01 vs. price of ₹409.05 (4% below fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the BOM:509079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gufic Biosciences Business Description

Other Exchanges GUFICBIO:India
Address SM House, 11 Sahakar Road, 1st to 4th Floor, Vile Parle (East), Mumbai, MH, IND, 400 057
Gufic Biosciences Ltd is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Geographically, it derives a majority of revenue from India. Its product portfolio includes Criticare, Criticare Life, Ferticare, Spark, Herbal, and other products. The company's lyophilized product includes antibiotics, anti-fungal, cardiac, infertility, anti-viral, and a proton-pump inhibitor. It derives maximum revenue from India.
73GF Score

Get the complete analysis for BOM:509079

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹409.05
Price
₹426.01
GF Value